Skip to content
The Nexus
DossierENTITY

cetirizine hydrochloride

Coverage of cetirizine hydrochloride in the Nexus archive.

Earliest in view: Jul 21 · 16:24 UTCMost recent: Jul 23 · 20:19 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 23 · 20:19 UTCWAFB BATON ROUGE
    Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills

    An over-the-counter allergy medication, cetirizine hydrochloride, sold nationwide by Unique Pharmaceutical Laboratories is being recalled due to contamination with ranitidine (Zantac). The FDA confirmed the recall, which was triggered by a pharmacy technician noticing incorrect pill colors. The mix-up could cause life-threatening reactions in individuals hypersensitive to ranitidine.

  • HEALTHJul 23 · 20:19 UTCWBTV CHARLOTTE
    Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills

    Unique Pharmaceutical Laboratories is recalling cetirizine hydrochloride tablets (generic Zyrtec) due to contamination with ranitidine (Zantac), which could cause life-threatening reactions in hypersensitive individuals. The FDA confirmed the recall after a pharmacy technician identified wrong-colored pills in the bottles. No illnesses have been reported.

  • HEALTHJul 23 · 20:19 UTCWSMV4 NASHVILLE
    Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills

    Unique Pharmaceutical Laboratories is recalling cetirizine hydrochloride tablets, a generic allergy medication, due to contamination with ranitidine (Zantac). The recall was prompted by a pharmacy technician noticing incorrect pills, but no illnesses have been reported.

  • HEALTHJul 21 · 16:24 UTCWSOC ABC CHARLOTTE
    Recall alert: Cetirizine Hydrochloride recalled over cross-contamination

    The FDA has issued a nationwide recall of four lots of Cetirizine Hydrochloride Tablets USP 5 mg produced by Unique Pharmaceuticals due to potential cross-contamination with ranitidine. The affected lots, identified by NDC 16571-401-10 and expiration dates 10/2028, may cause severe allergic reactions in individuals sensitive to ranitidine. No adverse effects have been reported, and consumers are advised to contact Rising Pharma Holdings for further information.

cetirizine hydrochloride · Dossier · The Nexus